Allele and genotype frequencies of CYP2C9 in a Korean population

被引:82
作者
Bae, JW
Kim, HK
Kim, JH
Yang, SI
Kim, MJ
Jang, CG
Park, YS
Lee, SY
机构
[1] Sungkyunkwan Univ, Coll Pharm, Pharmacol Lab, Suwon 440746, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Paediat, Seoul, South Korea
关键词
allele; CYP2C9; genotype; Korean;
D O I
10.1111/j.1365-2125.2005.02448.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To determine the frequencies of the variant alleles and the genotypes of CYP2C9 in a Korean population. Methods Three hundred and fifty-eight healthy Korean subjects were studied. CYP2C9 alleles were detected by polymerase chain reaction-restriction fragment length polymorphism assays and direct sequencing assays. Results The allele frequencies were 0.934 for CYP2C9*1, 0.060 for CYP2C9*3 and 0.006 for CYP2C9*13. The CYP2C9*2,*4,*5 and *11 alleles were not detected. The frequencies of the CYP2C9*1/*1, *1/*3 and *1/*13 genotypes were 0.869, 0.120 and 0.011, respectively. Conclusion The frequency of the CYP2C9*3 allele in the Korean population studied was significantly higher than reported elsewhere, and a novel allele, CYP2C9*13, was found at a frequency of 0.006 (95% confidence interval 0, 0.012). Only three genotypes of CYP2C9, CYP2C9*1/*1,*1/*3 and *1/*13 were observed in this Korean population.
引用
收藏
页码:418 / 422
页数:5
相关论文
共 22 条
[1]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[2]   Functional impact of CYP2C*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans [J].
Allabi, AC ;
Gala, JL ;
Horsmans, Y ;
Babaoglu, MO ;
Bozkurt, A ;
Heusterspreute, M ;
Yasar, U .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (02) :113-118
[3]  
[Anonymous], HUMAN CYTOCHROME P45
[4]   Discovery of new potentially defective alleles of human CYP2C9 [J].
Blaisdell, J ;
Jorge-Nebert, LF ;
Coulter, S ;
Ferguson, SS ;
Lee, SJ ;
Chanas, B ;
Xi, T ;
Mohrenweiser, H ;
Ghanayem, B ;
Goldstein, JA .
PHARMACOGENETICS, 2004, 14 (08) :527-537
[5]   GENE STRUCTURE AND UPSTREAM REGULATORY REGIONS OF HUMAN CYP2C9 AND CYP2C18 [J].
DEMORAIS, SMF ;
SCHWEIKL, H ;
BLAISDELL, J ;
GOLDSTEIN, JA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (01) :194-201
[6]   Cytochrome P4502C9 (CYP2C9) allele frequencies in canadian native indian and inuit populations [J].
Gaedigk, A ;
Casley, WL ;
Tyndale, RF ;
Sellers, EM ;
Jurima-Romet, M ;
Leeder, JS .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2001, 79 (10) :841-847
[7]   Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus [J].
Imai, J ;
Ieiri, I ;
Mamiya, K ;
Miyahara, S ;
Furuumi, H ;
Nanba, E ;
Yamane, M ;
Fukumaki, Y ;
Ninomiya, H ;
Tashiro, N ;
Otsubo, K ;
Higuchi, S .
PHARMACOGENETICS, 2000, 10 (01) :85-89
[8]   Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population [J].
Kimura, M ;
Ieiri, I ;
Mamiya, K ;
Urae, F ;
Higuchi, S .
THERAPEUTIC DRUG MONITORING, 1998, 20 (03) :243-247
[9]   Cytochrome P4502C9 polymorphisms: a comprehensive review of the in-vitro and human data [J].
Lee, CR ;
Goldstein, JA ;
Pieper, JA .
PHARMACOGENETICS, 2002, 12 (03) :251-263
[10]   The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: Studies in stereoselective hydroxylation and population pharmacokinetics [J].
Mamiya, K ;
Ieiri, I ;
Shimamoto, J ;
Yukawa, E ;
Imai, J ;
Ninomiya, H ;
Yamada, H ;
Otsubo, K ;
Higuchi, S ;
Tashiro, N .
EPILEPSIA, 1998, 39 (12) :1317-1323